Brigham Womens Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRIGHAM WOMENS, and what generic and branded alternatives to BRIGHAM WOMENS drugs are available?
BRIGHAM WOMENS has two approved drugs.
Drugs and US Patents for Brigham Womens
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brigham Womens | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203816-001 | Oct 30, 2014 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Brigham Womens Hosp | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 203783-001 | Oct 30, 2014 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.